About Biocent
Biocent is a Healthcare company. Development and marketing of pharmaceutical medicines in nephrology, cardiology, urology, and gastroenterology. Its Indian entity Biocent Scientific India Private Limited reported revenue of ₹3.53 Cr. Biocent offers products and services including Nephrology Medicines and Cardiology Medications. Its focus areas include Pharmaceuticals, Therapeutic Medicines, Cardiology and Nephrology.
Company details
Biocent is recognized as a pharmaceutical company that develops, manufactures, and markets high-quality medicines in key therapeutic areas such as nephrology, cardiology, urology, and gastroenterology. Innovation is emphasized through research and development efforts that focus on novel drug delivery systems to enhance patient outcomes. Quality control is maintained by adhering to global standards like GMP and ISO certifications, ensuring safety and efficacy. Partnerships with healthcare professionals are fostered to address unmet medical needs, while corporate social responsibility initiatives are undertaken to improve healthcare access and promote health education. Overall, a commitment to integrity and excellence is demonstrated in operations that aim to benefit patients and communities.
- SectorsHealthcare
- Website biocent.in
- Legal Name Biocent Scientific India Private Limited
- Date of Incorporation 11 Nov, 2016
- Jurisdiction Kanayannur, Kerala, India
- Indian entity revenue₹3.53 Cr
FY 2025 · +51% YoY
- Indian entity net profit₹28.3 Lakh
FY 2025 · 8% margin
- Indian entity EBITDA₹60.5 Lakh
FY 2025 · 17% margin
Associated legal entities of Biocent
Biocent operates through Biocent Scientific India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biocent Scientific India Private Limited CIN U24290KL2016PTC047256 | Active | 11 Nov 2016 | Kanayannur, Kerala | ₹3.5 Cr | 3 | View details |
Products & Services of Biocent
Biocent offers a comprehensive portfolio of products and services, including Nephrology Medicines and Cardiology Medications.
Medicines for kidney-related diseases are developed and marketed by Biocent in areas like chronic kidney disease.
Cardiovascular medications are provided by Biocent for conditions such as hypertension and heart failure.
Board of directors of Biocent Scientific India Private Limited (Biocent)
Biocent Scientific India Private Limited is the primary company behind Biocent. The board of Biocent Scientific India Private Limited currently have 3 directors; the longest-serving is Preeti Mathew, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Preeti Mathew DIN 02987862 | Director | 11 Nov 2016 | 10 yrs | Biocent Scientific India Private Limited |
| Stelinpullamkottu Mathai DIN 02987904 | Director | 11 Nov 2016 | 10 yrs | Biocent Scientific India Private Limited |
| Vijo Thomas DIN 07639619 | Managing Director | 11 Nov 2016 | 10 yrs | Biocent Scientific India Private Limited |
Financials of Biocent
Figures of Biocent Scientific India Private Limited, the primary company behind Biocent, for FY 2025. Revenue was ₹3.53 Cr (+51% year on year). Net profit was ₹28.3 Lakh (8% margin). EBITDA was ₹60.5 Lakh (17% margin). Revenue has grown at a compounded annual rate of +46% over three years and +42% over five years.
- ₹3.53 CrRevenue · FY 2025 · +51% YoY
- ₹28.3 LakhNet profit · 8% margin
- ₹60.5 LakhEBITDA · 17% margin
- ₹1 LakhPaid-up capital
- +46%Revenue CAGR, 3 years
- +42%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Biocent Scientific India Private Limited are on its company page.
Detailed financial statements for Biocent
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biocent
The primary company behind Biocent, Biocent Scientific India Private Limited, reported revenue of ₹3.53 Cr for FY 2025, up 51% year on year.
Biocent is recognized as a pharmaceutical company that develops, manufactures, and markets high-quality medicines in key therapeutic areas such as nephrology, cardiology, urology, and gastroenterology. Innovation is emphasized through research and development efforts that focus on novel drug delivery systems to enhance patient outcomes. Quality control is maintained by adhering to global standards like GMP and ISO certifications, ensuring safety and efficacy. Partnerships with healthcare professionals are fostered to address unmet medical needs, while corporate social responsibility initiatives are undertaken to improve healthcare access and promote health education. Overall, a commitment to integrity and excellence is demonstrated in operations that aim to benefit patients and communities.
Biocent offers Nephrology Medicines and Cardiology Medications.
Biocent operates through Biocent Scientific India Private Limited.
The legal entities of Biocent currently have 3 directors, including Preeti Mathew, Stelinpullamkottu Mathai, Vijo Thomas.